No existing medicine can defeat dengue. It’s one of the top ten threats to global public health, and as the effects of global warming begin to bite, the stage is set for its spread outward from the tropics. This looks like a job for medicine makers without borders, doesn’t it? Here to walk us through DNDi’s opening gambit against this neglected, climate-sensitive disease are Panisadee Avirutnan of Mahidol University and the DNDi’s own Isebela Ribeiro. Is there an open source path to victory here? Can the nonprofit model stop dengue in its tracks?

Panisadee Avirutnan is an Associate Professor in the Department of Immunology at Mahidol University in Bangkok.

Isabela Ribeiro is the Director of DNDi’s Viral Diseases Cluster.

Mentioned in the episode

the rise of dengue in Southeast Asia
South-South leadership and cooperation
the four serotypes of dengue

Read more from the sharpest minds in pharma at 
themedicinemaker.com

If you have thoughts on anything you heard in this episode and want to share them or contribute to the magazine, then drop me an email at angus.stewart@texerepublishing.com

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Texere Publishing. Innehållet i podden är skapat av Texere Publishing och inte av, eller tillsammans med, Poddtoppen.